Effect of morbid obesity on kinetic of desflurane wash-in wash-out curves and recovery times

Minerva Anestesiologica

Volumn 73, Issue 5, 2007, Pages 275-279

  La Colla, G ^a   La Colla, L ^b   Turi, S ^b   Poli, D ^b   Albertin, A ^b   Pasculli, N ^b   Bergonzi, Pier Carlo ^b   Gonfalini, M ^b   Ruggieri, F ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Desflurane; Kinetics; Obesity; Remifentanil

Indexed keywords

ATROPINE; DESFLURANE; NEOSTIGMINE; PROPOFOL; REMIFENTANIL;

ADULT; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DOSE TITRATION; DRUG UPTAKE; ENDOTRACHEAL INTUBATION; EXTUBATION; FEMALE; FIBEROPTIC BRONCHOSCOPY; GENERAL ANESTHESIA; HUMAN; LUNG VENTILATION; MALE; MORBID OBESITY; OPERATION DURATION; PATIENT INFORMATION; PREMEDICATION; RESPIRATORY TRACT PARAMETERS; SUTURE;

ADULT; AGED; ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; FEMALE; HUMANS; INTUBATION, INTRATRACHEAL; ISOFLURANE; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; OBESITY, MORBID; PIPERIDINES;

EID: 34447118090     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Auler JO Jr, Miyoshi E, Fernandes CR. The effects of abdominal opening on respiratory mechanics during general anesthesia in normal and morbidly obese patients: a comparative study. Anesth Analg 2002;94:741-8.
2. Alpert MA, Hashimi VW. Obesity and the heart. Am J Med Sci 1989;306:117-23.
3. Bray GA. Pathophysiology of obesity. Am J Clin Nutr 1992;55:488S-94S
4. Juvin P, Vidam C, Malek, Dupont H, Marmuse JP, Desmonts JM. Postoperative recovery after desflurane, propofol, or isoflurane anesthesia among morbidly obese patients: a prospective randomized study. Anesth Analg 2000;91:714-9.
5. Arain SR, Barth CD, Shankar H, Eberth TJ. Choice of volatile anesthetic for the morbidly obese patients: sevoflurane or desflurane. J Clin Anesth 2005;17:413-9.
6. Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJM, Gambus PL et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997;86:10-23.
7. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997;86:24-33.
8. Lemmens Hj, Brodsky JB, Bernstein DP. Estimating ideal body weight: a new formula. Obes Surg 2005;15:1082-3.
9. Cheymol G. Effects of obesity on pharmacokinetic implications for drug therapy. Clin Pharmacokinet 2000;39:215-31.
10. Strum DP, Eger EI 2nd. Partition coefficients of desflurane in human blood, saline, and olive oil. Anesth Analg 1987;66:971-3.
11. Yasuda N, Eger EI 2nd, Weiskopf RB, Tanifuji Y, Kobayashi K. Solubility of desflurane (I-653), sevoflurane, isoflurane, and halothane in human blood. Masui 1991;40:1059-62.
12. Wissing H, Kuhn I, Rietbrock S, Fuhr U. Pharmacokinetic of inhaled anaesthetic in a clinical setting: comparison of desflurane, isoflurane and sevoflurane. Br J Anaesth 2000;84:443-9.
13. Salvo I, Torri G, Calderini E. Farmacocinetica degli anestetici per inalazione. In: Torri G, editor. Gli anestetici per inalazione. Milano: Anestesia e Rianimazione Ed.; 1990.p.47-58.
14. Stoelting RK, Eger EI 2nd. An additional explanation for the second gas effect: a concentrating effect. Anesthesiology 1969;30:273-7.
15. Casati A, Bignami E, Spreafico E, Mamo D. Effects of obesity on wash-in and wash-out curves of sevoflurane. Eur J Anaesthesiol 2004;21:243-5.
16. Eger II E, Gong D, Koblin D, Bowland T, Ionescu P, Laster M et al. The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A, in volunteers. Anesth Analg 1998;86:414-21.
17. Eger II E, Saidman LJ. Illustrations of inhaled anesthetic uptake, including intertissue diffilsion to and from fat. Anesth Analg 2005;100:1020-33.
18. Bolinder J, Kerckhoffs DA, Moberg I, Hagstrom-Toft E, Arner P. Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes 2000;49:797-802.
19. Schrincker T, Galeone M, Wykes L, Carli F. Effect of desflurane/ remifentanil anaesthesia on glucose metabolim during surgery: a comparison with desflurane/epidural anaesthesia. Acta Anaesthesiol Scand 2004;48:169-73.
20. Fisher A, Waterhouse TD, Adams AP. Obesity: its relation to anaesthesia. Anaesthesia 1975;30:633-47.
21. Voyagis GS, Kyriakis KP, Dimitriou V, Vrettou I. Value of oropharyngeal Mallampati classification in predicting difficult laryngoscopy among obese patients. Eur J Anaesthesiol 1998;15:330-4.
22. Carpenter RL, Eger EI 2nd, Johnson BH, Unadkat JD, Sheiner LB. Does the duration of anesthetic administration affect the pharmacokinetics or metabolism of inhaled anesthetics in humans? Anesth Analg 1987;66:1-8.
23. Rietbrock S, Wissing H, Kuhn I, Fuhr U. Pharmacokinetics of inhaled anaesthetics in a clinical setting: evaluation of a method based on routine monitoring data. Br J Anaesth 2000:84:437-42.